Eurofins is proud to announce the acquisition of Dermscan Group, a well-recognized testing company with a global laboratory network.

Over the last 28 years Dermscan has built a significant reputation for excellence in safety, efficacy, clinical studies and in-vitro testing, serving the cosmetics, personal care, and pharmaceutical industries.
Eurofins welcomes the unmatched expertise in cosmetic testing from Dermscan in a market where the expectancy for safety and efficacy is among the highest in the world.

Dermscan, on its turn, brings to Eurofins Cosmetics innovative capabilities as well as strong competences from its international teams of experts based in France, Poland, Tunisia, Thailand and Mauritius.

In line with Eurofins Cosmetics’ strategy to expand its leading global cosmetic testing footprint, this acquisition reinforces the position of Eurofins Cosmetics, now counting with over 40 state-of-the-art laboratories active in the field across Europe, North America, Asia, Australia and Africa, offering an unrivalled range of clinical, sensory, chemical, in-vitro and microbiological testing services.

<<We are confident that this acquisition will contribute to the expansion of footprint and strengthening of our expertise in the cosmetics testing industry by offering an increasingly wider scope of top-class services and facilitating the development of innovative new solutions for our customers>>… explains Stéphane Barrau, Vice President of Eurofins Consumer Product Testing.>>

Frédérique Girard-Ory, General Manager of Dermscan, comments:
<<This is a new adventure and a new challenge for the entire Dermscan’s team that we are very excited to undertake. Joining Eurofins will enable us to propose an even more complete and diversified offer to the cosmetics industry.>>

About Dermscan

Established in 1990 and in continuous expansion ever since, Dermscan is headquartred in Lyon, France, and present today in Tunisia (Tunis), Poland (Gdansk), Thailand (Bangkok) and Mauritius (Quatre Bornes).
The company employs over 150 highly skilled staff.

Dermscan has established a significant reputation for excellence in safety, efficacy and in-vitro testing and clinical studies, serving the cosmetics, personal care, and pharmaceutical industries in Europe, Asia and Africa, counting today with a broad international clients portfolio.